BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26413869)

  • 1. LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.
    Peña CG; Nakada Y; Saatcioglu HD; Aloisio GM; Cuevas I; Zhang S; Miller DS; Lea JS; Wong KK; DeBerardinis RJ; Amelio AL; Brekken RA; Castrillon DH
    J Clin Invest; 2015 Nov; 125(11):4063-76. PubMed ID: 26413869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas.
    Contreras CM; Gurumurthy S; Haynie JM; Shirley LJ; Akbay EA; Wingo SN; Schorge JO; Broaddus RR; Wong KK; Bardeesy N; Castrillon DH
    Cancer Res; 2008 Feb; 68(3):759-66. PubMed ID: 18245476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy.
    Contreras CM; Akbay EA; Gallardo TD; Haynie JM; Sharma S; Tagao O; Bardeesy N; Takahashi M; Settleman J; Wong KK; Castrillon DH
    Dis Model Mech; 2010; 3(3-4):181-93. PubMed ID: 20142330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of tyrosine threonine kinase inhibits tumor growth via G2/M arrest in human endometrioid endometrial adenocarcinoma.
    Zhang J; Jiang Y; Zhao Y; Wang W; Xie Y; Wang H; Yang Y
    Tumour Biol; 2017 Jul; 39(7):1010428317712444. PubMed ID: 28718377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.
    Co NN; Iglesias D; Celestino J; Kwan SY; Mok SC; Schmandt R; Lu KH
    Cancer; 2014 Nov; 120(22):3457-68. PubMed ID: 25042259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition.
    Cheng H; Liu P; Zhang F; Xu E; Symonds L; Ohlson CE; Bronson RT; Maira SM; Di Tomaso E; Li J; Myers AP; Cantley LC; Mills GB; Zhao JJ
    Cancer Res; 2014 Jan; 74(1):15-23. PubMed ID: 24322983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
    Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
    Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
    Gao Y; Lin P; Lydon JP; Li Q
    J Pathol; 2017 Sep; 243(1):89-99. PubMed ID: 28657664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma.
    Kübler K; Ayub TH; Weber SK; Zivanovic O; Abramian A; Keyver-Paik MD; Mallmann MR; Kaiser C; Serçe NB; Kuhn W; Rudlowski C
    Gynecol Oncol; 2014 Nov; 135(2):176-83. PubMed ID: 25173585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATF4 regulates CCL2 expression to promote endometrial cancer growth by controlling macrophage infiltration.
    Liu B; Chen P; Xi D; Zhu H; Gao Y
    Exp Cell Res; 2017 Nov; 360(2):105-112. PubMed ID: 28843961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.
    Koyama S; Akbay EA; Li YY; Aref AR; Skoulidis F; Herter-Sprie GS; Buczkowski KA; Liu Y; Awad MM; Denning WL; Diao L; Wang J; Parra-Cuentas ER; Wistuba II; Soucheray M; Thai T; Asahina H; Kitajima S; Altabef A; Cavanaugh JD; Rhee K; Gao P; Zhang H; Fecci PE; Shimamura T; Hellmann MD; Heymach JV; Hodi FS; Freeman GJ; Barbie DA; Dranoff G; Hammerman PS; Wong KK
    Cancer Res; 2016 Mar; 76(5):999-1008. PubMed ID: 26833127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LKB1 loss at transcriptional level promotes tumor malignancy and poor patient outcomes in colorectal cancer.
    He TY; Tsai LH; Huang CC; Chou MC; Lee H
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S703-10. PubMed ID: 24879590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
    Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
    Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LKB1 as a Tumor Suppressor in Uterine Cancer: Mouse Models and Translational Studies.
    Peña CG; Castrillón DH
    Adv Exp Med Biol; 2017; 943():211-241. PubMed ID: 27910069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells.
    Roy BC; Kohno T; Iwakawa R; Moriguchi T; Kiyono T; Morishita K; Sanchez-Cespedes M; Akiyama T; Yokota J
    Lung Cancer; 2010 Nov; 70(2):136-45. PubMed ID: 20207041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OCT4 pseudogene 5 upregulates OCT4 expression to promote proliferation by competing with miR-145 in endometrial carcinoma.
    Bai M; Yuan M; Liao H; Chen J; Xie B; Yan D; Xi X; Xu X; Zhang Z; Feng Y
    Oncol Rep; 2015 Apr; 33(4):1745-52. PubMed ID: 25634023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling.
    Xiong S; Klausen C; Cheng JC; Zhu H; Leung PC
    Oncotarget; 2015 Oct; 6(31):31659-73. PubMed ID: 26384307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
    Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
    Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.